Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Dr. John Liddicoat was named Executive Vice President and President, Americas Region in September 2018, and serves as a member of the Medtronic Executive Committee.
Dr. Liddicoat joined Medtronic in 2006 as Vice President of Atrial Fibrillation Technologies. In December of 2006, John was named Vice President and General Manager of the Structural Heart Disease Business, which expanded his responsibilities to include the global operations of the surgical and transcatheter valve product portfolios. Soon thereafter, John assumed the leadership responsibilities of the entire Structural Heart business, and he was named the Senior Vice President and President of the Medtronic Structural Heart division. Under his leadership, the Structural Heart division doubled in revenue through a series of organic and acquisition activities.
Beginning in August 2014, Dr. Liddicoat served as Senior Vice President and President, Cardiac Rhythm and Heart Failure (CRHF) Division. In this role, he was responsible for the overall strategic direction and day-today global operations of five business units covering the diagnosis, treatment, and management of patients with cardiac dysrhythmias and heart failure with an annual revenue approaching $6B.
Dr. Liddicoat is a cardiothoracic surgeon who, prior to joining Medtronic, most recently practiced at the Beth Israel Deaconess Medical Center in Boston where he also held an appointment as Assistant Professor of Surgery at Harvard Medical School. John earned an MBA from Boston University, a doctor of medicine from the University of Chicago, and a bachelor’s degree from the University of Michigan. He completed his surgical training in general and cardiothoracic surgery at Johns Hopkins Hospital in Baltimore. Prior to joining Medtronic, Dr. Liddicoat founded two medical device companies, and served as a consultant to several venture capital firms and medical device companies.